116 related articles for article (PubMed ID: 25207944)
21. Retinal imaging in the twenty-first century: state of the art and future directions.
Keane PA; Sadda SR
Ophthalmology; 2014 Dec; 121(12):2489-500. PubMed ID: 25282252
[TBL] [Abstract][Full Text] [Related]
22. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema.
Rayess N; Rahimy E; Ying GS; Bagheri N; Ho AC; Regillo CD; Vander JF; Hsu J
Am J Ophthalmol; 2015 Jan; 159(1):85-91.e1-3. PubMed ID: 25261844
[TBL] [Abstract][Full Text] [Related]
23. Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis.
Pratt NL; Ramsay EN; Kemp A; Kalisch-Ellett LM; Shakib S; Caughey GE; Ryan P; Graves S; Roughead EE
Drug Saf; 2014 Dec; 37(12):1021-7. PubMed ID: 25260802
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
25. Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.
Ho M; Lo EC; Young AL; Liu DT
Eye (Lond); 2014 Dec; 28(12):1469-76. PubMed ID: 25257771
[TBL] [Abstract][Full Text] [Related]
26. Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions.
Biagi C; Conti V; Montanaro N; Melis M; Buccellato E; Donati M; Covezzoli A; Amato R; Pazzi L; Venegoni M; Vaccheri A; Motola D
Eur J Clin Pharmacol; 2014 Dec; 70(12):1505-12. PubMed ID: 25234795
[TBL] [Abstract][Full Text] [Related]
27. Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.
Eadie JA; Gottlieb JL; Ip MS; Blodi BA; Danis RP; Chandra SR; Nork TM; Altaweel MM; Stern-Hogan BS
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(5):394-7. PubMed ID: 25230402
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life.
Inoue M; Arakawa A; Yamane S; Kadonosono K
Clin Ophthalmol; 2014; 8():1711-6. PubMed ID: 25228787
[TBL] [Abstract][Full Text] [Related]
29. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
[TBL] [Abstract][Full Text] [Related]
30. The spectrum of superficial and deep capillary ischemia in retinal artery occlusion.
Yu S; Pang CE; Gong Y; Freund KB; Yannuzzi LA; Rahimy E; Lujan BJ; Tabandeh H; Cooney MJ; Sarraf D
Am J Ophthalmol; 2015 Jan; 159(1):53-63.e1-2. PubMed ID: 25244976
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome and risk of age-related macular degeneration.
Ghaem Maralani H; Tai BC; Wong TY; Tai ES; Li J; Wang JJ; Mitchell P
Retina; 2015 Mar; 35(3):459-66. PubMed ID: 25207946
[TBL] [Abstract][Full Text] [Related]
32. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):45-50. PubMed ID: 25317632
[TBL] [Abstract][Full Text] [Related]
33. Induction with intravitreal bevacizumab every two weeks in the management of neovascular age-related macular degeneration.
Barikian A; Mahfoud Z; Abdulaal M; Safar A; Bashshur ZF
Am J Ophthalmol; 2015 Jan; 159(1):131-7. PubMed ID: 25308787
[TBL] [Abstract][Full Text] [Related]
34. Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Augustine H; Munro M; Adatia F; Webster M; Fielden M
Can J Ophthalmol; 2014 Oct; 49(5):458-63. PubMed ID: 25284103
[TBL] [Abstract][Full Text] [Related]
35. Predictive findings of visual outcome in spectral domain optical coherence tomography after ranibizumab treatment in age-related macular degeneration.
Kwon YH; Lee DK; Kim HE; Kwon OW
Korean J Ophthalmol; 2014 Oct; 28(5):386-92. PubMed ID: 25276080
[TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy.
Ferraz DA; Vasquez LM; Preti RC; Motta A; Sophie R; Bittencourt MG; Sepah YJ; Monteiro ML; Nguyen QD; Takahashi WY
Retina; 2015 Feb; 35(2):280-7. PubMed ID: 25272318
[TBL] [Abstract][Full Text] [Related]
37. Dominant cystoid macular dystrophy.
Saksens NT; van Huet RA; van Lith-Verhoeven JJ; den Hollander AI; Hoyng CB; Boon CJ
Ophthalmology; 2015 Jan; 122(1):180-91. PubMed ID: 25267528
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
[TBL] [Abstract][Full Text] [Related]
39. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.
Zarranz-Ventura J; Carreño E; Johnston RL; Mohammed Q; Ross AH; Barker C; Fonollosa A; Artaraz J; Pelegrin L; Adan A; Lee RW; Dick AD; Sallam A
Am J Ophthalmol; 2014 Dec; 158(6):1136-1145.e5. PubMed ID: 25217856
[TBL] [Abstract][Full Text] [Related]
40. Retinal hemorheologic characterization of early-stage diabetic retinopathy using adaptive optics scanning laser ophthalmoscopy.
Arichika S; Uji A; Murakami T; Unoki N; Yoshitake S; Dodo Y; Ooto S; Miyamoto K; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 Sep; 55(12):8513-22. PubMed ID: 25212778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
